PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • Global ambulatory ECG market – Market size and forecast 2017-2022 • Global ambulatory cardiac event monitors market – Market size and forecast 2017-2022 • Global ambulatory cardiac telemetry devices market – Market size and forecast 2017-2022 • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: MARKET SEGMENTATION BY END-USER • Segmentation by end-user PART 10: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Ambulatory cardiac monitoring devices market in Americas – Market size and forecast 2017-2022 • Ambulatory cardiac monitoring devices market in EMEA – Market size and forecast 2017-2022 • Ambulatory cardiac monitoring devices market in APAC – Market size and forecast 2017-2022 • Key leading countries • Market opportunity PART 11: DECISION FRAMEWORK PART 12: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 13: MARKET TRENDS • Development of new products • Growing popularity of extended continuous cardiac monitoring • Advances in ambulatory cardiac monitoring devices PART 14: VENDOR LANDSCAPE • Overview • Landscape disruption PART 15: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • BioTelemetry • General Electric • iRhythm Technologies • Medicomp • Medtronic PART 16: APPENDIX • List of abbreviations   Exhibit 01: Parent market Exhibit 02: Global cardiac monitoring devices market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global ambulatory cardiac monitoring devices market – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global ambulatory cardiac monitoring devices market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Product – Market share 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: Ambulatory ECG – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Ambulatory ECG – Year-over-year growth 2018-2022 (%) Exhibit 22: Ambulatory cardiac event monitors – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Ambulatory cardiac event monitors – Year-over-year growth 2018-2022 (%) Exhibit 24: Ambulatory cardiac telemetry devices – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Ambulatory cardiac telemetry devices – Year-over-year growth 2018-2022 (%) Exhibit 26: Market opportunity by product Exhibit 27: Customer landscape Exhibit 28: Geography – Market share by 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Americas – Year-over-year growth 2018-2022 (%) Exhibit 32: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 33: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 35: APAC – Year-over-year growth 2018-2022 (%) Exhibit 36: Key leading countries Exhibit 37: Market opportunity Exhibit 38: Vendor landscape Exhibit 39: Landscape disruption Exhibit 40: Vendors covered Exhibit 41: Vendor classification Exhibit 42: Market positioning of vendors Exhibit 43: BioTelemetry -overview Exhibit 44: BioTelemetry – Business segments Exhibit 45: BioTelemetry – Organizational developments Exhibit 46: BioTelemetry – Segment focus Exhibit 47: BioTelemetry – Key offerings Exhibit 48: General Electric -overview Exhibit 49: General Electric – Business segments Exhibit 50: General Electric – Organizational developments Exhibit 51: General Electric – Geographic focus Exhibit 52: General Electric – Segment focus Exhibit 53: General Electric – Key offerings Exhibit 54: iRhythm Technologies -Overview Exhibit 55: iRhythm Technologies – Business segments Exhibit 56: iRhythm Technologies – Organizational developments Exhibit 57: iRhythm Technologies – Key offerings Exhibit 58: Medicomp - Overview Exhibit 59: Medicomp – Product segments Exhibit 60: Medicomp – Organizational developments Exhibit 61: Medicomp – Key offerings Exhibit 62: Medtronic -Overview Exhibit 63: Medtronic – Business segments Exhibit 64: Medtronic – Organizational developments Exhibit 65: Medtronic – Geographic focus Exhibit 66: Medtronic – Segment focus Exhibit 67: Medtronic – Key offerings

BioTelemetry General Electric iRhythm Technologies Medicomp Medtronic